ARCHIVES

ODAC Votes For Accelerated Approval For Adcetris For Two Lymphoma Indications

This article is from The Cancer Letter archive.

Vol. 37 No. 29 | July 22, 2011

Download PDF Visit The Full Archive

Related Articles

NIH Offers Grant Funds for Support of Minority, Disabled Researchers

February 16, 1996

FDA Approves Afinitor For pNET; No Word On Sutent For Same Use

May 6, 2011

Workshop Suggests Confirmation of Vitamin C Studies

December 7, 1990

“Alternative” Is Misleading Term, President’s Cancer Panel Writes To Healy

February 5, 1993

Reimbursement: NCI, VA Begin Project On Clinical Trials Access For Veterans

January 17, 1997

PRI Asks NIH To Cancel Recompetition Of Frederick Center Operations Contract

February 17, 1995